Semaglutide
Semaglutide is an FDA-approved GLP-1 receptor agonist that reduces appetite and slows gastric emptying to support sustained weight loss. In clinical trials, patients lost an average of 15% of body weight. Available in 1-month and 3-month provider-guided protocols.
Get Started
Choose Your Program
Three tiers designed for different starting points and goals. All programs include provider-guided dosing.
Month 1
0.25mg/week
(weeks 1–4)
Month 2
0.5mg/week
(weeks 5–8)
Month 3
1mg/week
(weeks 9–12)
* That is a typical patient dosing schedule. A licensed provider will determine your final dose and schedule after your consultation.
Who It's For
Indicated for adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related comorbidity. Requires a provider consultation and prescription. Our team reviews your intake and confirms eligibility within one business day.
How to Use
⚕Semaglutide is administered as a once-weekly subcutaneous injection. Protocols begin at 0.25 mg weekly and are titrated upward over approximately 16-20 weeks to a typical maintenance dose of 1.0 to 2.4 mg weekly, based on individual tolerability and provider guidance.
FAQ
Common Questions
How is Semaglutide different from Tirzepatide?+
Semaglutide is a single-mechanism GLP-1 agonist with a strong clinical track record. Tirzepatide adds a GIP component that tends to produce slightly greater average weight loss. Both are proven medications. Your provider will recommend the right fit for your history and goals.
What results can I expect?+
Most patients notice appetite reduction within the first 2-4 weeks. Average weight loss in clinical trials was approximately 15% of body weight over 68 weeks on the full maintenance dose.
Are there side effects?+
The most common side effects are nausea, diarrhea, and constipation, particularly during the titration phase. Gradual dose increases minimize these effects. Your provider will review your full risk profile before prescribing.
How long do I stay on the protocol?+
Most patients stay on their protocol for a minimum of 3-6 months to achieve and stabilize results. Your provider will assess your progress and adjust based on your response and goals.